Tanabe Pharma

LAUSANNE, Switzerland, October 29, 2026 ADC Therapeutics SA has announced an important regulatory and commercial development for ZYNLONTA® (loncastuximab...

BALLERUP, Denmark — September 18, 2026 LEO Pharma announced that the U.S. Food and Drug Administration (FDA) has accepted...